Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma.
Hu
Lang
L
Department of Epidemiology, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region,People’s Republic of China. hulang2000060@sina.com
Chen
Gang
G
Yu
Hongping
H
Qiu
Xiaoqiang
X
DNA; Hepatocellular carcinoma; Immunohistochemistry; Promoter hypermethylation; RASSF1A; Tissue microarrays (TMAs)